OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Profiling of the chemical space on the phenyl group of substituted benzothiazole RIPK3 inhibitors
Yue Xu, Caiquan Liang, Wannian Zhang, et al.
Bioorganic Chemistry (2022) Vol. 131, pp. 106339-106339
Closed Access | Times Cited: 7
Yue Xu, Caiquan Liang, Wannian Zhang, et al.
Bioorganic Chemistry (2022) Vol. 131, pp. 106339-106339
Closed Access | Times Cited: 7
Showing 7 citing articles:
Targeting Receptor-Interacting Protein Kinase 1 by Novel Benzothiazole Derivatives: Treatment of Acute Lung Injury through the Necroptosis Pathway
Xinqi Zhang, Qianyu Han, Ruilin Hou, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 7, pp. 5261-5278
Closed Access | Times Cited: 13
Xinqi Zhang, Qianyu Han, Ruilin Hou, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 7, pp. 5261-5278
Closed Access | Times Cited: 13
A natural chalcone cardamonin inhibits necroptosis and ameliorates dextran sulfate sodium (DSS)-induced colitis by targeting RIPK1/3 kinases
Xiaofei Shen, Hongqing Chen, Tian Wen, et al.
European Journal of Pharmacology (2023) Vol. 954, pp. 175840-175840
Closed Access | Times Cited: 8
Xiaofei Shen, Hongqing Chen, Tian Wen, et al.
European Journal of Pharmacology (2023) Vol. 954, pp. 175840-175840
Closed Access | Times Cited: 8
Insight from Linker Investigations: Discovery of a Novel Phenylbenzothiazole Necroptosis Inhibitor Targeting Receptor-Interacting Protein Kinase 1 (RIPK1) from a Phenoxybenzothiazole Compound with Dual RIPK1/3 Targeting Activity
Jingjie Fang, Houzong Yao, Chunlin Zhuang, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 22, pp. 15288-15308
Closed Access | Times Cited: 5
Jingjie Fang, Houzong Yao, Chunlin Zhuang, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 22, pp. 15288-15308
Closed Access | Times Cited: 5
A novel, rapid and eco-sustainable approach for the synthesis of novel benzothiazole derivatives as potent urease inhibitors: biological assay, molecular docking, dynamic simulation, DFT and ADMET studies
Billel Belhani, Mohamed Aissaoui, Hacène K’tir, et al.
Journal of Molecular Structure (2023) Vol. 1293, pp. 136221-136221
Closed Access | Times Cited: 4
Billel Belhani, Mohamed Aissaoui, Hacène K’tir, et al.
Journal of Molecular Structure (2023) Vol. 1293, pp. 136221-136221
Closed Access | Times Cited: 4
Analysis on benzothiazole necroptosis inhibitors with chiral substitutions in the solvent-accessible region of RIP kinase domain
Hongming Shao, Lijuan Xu, Gechang Li, et al.
Bioorganic Chemistry (2023) Vol. 137, pp. 106647-106647
Closed Access | Times Cited: 2
Hongming Shao, Lijuan Xu, Gechang Li, et al.
Bioorganic Chemistry (2023) Vol. 137, pp. 106647-106647
Closed Access | Times Cited: 2
Discovery of a Novel Benzimidazole Necroptosis Inhibitor from an In-House Compound Library
Yu Zou, Chai Yue, Hongming Shao, et al.
Pharmaceutical Fronts (2024) Vol. 06, Iss. 03, pp. e283-e293
Open Access
Yu Zou, Chai Yue, Hongming Shao, et al.
Pharmaceutical Fronts (2024) Vol. 06, Iss. 03, pp. e283-e293
Open Access
Anticancer activity of new quinolinyl–benzothiazolyl clubbed with amino acids and their in-silico studies
S. Shashidhar Bharadwaj, Boja Poojary, Sathish Kumar Boda, et al.
Journal of the Iranian Chemical Society (2024)
Closed Access
S. Shashidhar Bharadwaj, Boja Poojary, Sathish Kumar Boda, et al.
Journal of the Iranian Chemical Society (2024)
Closed Access
